These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1622060)

  • 1. Thrombogenic and vasoactive effects of smoking--with special reference to peripheral arterial occlusive disease.
    Lassila R
    Ann Chir Gynaecol; 1992; 81(2):107-9. PubMed ID: 1622060
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on haematocrit in peripheral arterial disease.
    Lowe GD; Saniabadi A; Turner A; Lieberman P; Pollock J; Drury J
    Klin Wochenschr; 1986 Oct; 64(19):969-74. PubMed ID: 3784449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mutation in factor II and factor V gene in patients with peripheral arterial occlusive disease].
    Abukishe A; Brandt M; Hedderich J; Hirt S; Lentz S; Schäfer H; Walluscheck K; Cremer J; Bruhn HD
    Hamostaseologie; 2006 Aug; 26(3):197-200. PubMed ID: 16906235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Smoking cessation using alternative nicotine administration in patients with peripheral arterial occlusive disease. Effects on peripheral circulation, hematologic parameters and lipoprotein status].
    Diehm C; Emmerich M; Schork M; Schöckel KH
    Vasa Suppl; 1990; 29():1-53. PubMed ID: 2377961
    [No Abstract]   [Full Text] [Related]  

  • 5. Smoking and occlusive peripheral arterial disease. Clinical review.
    Lepäntalo M; Lassila R
    Eur J Surg; 1991 Feb; 157(2):83-7. PubMed ID: 1676315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Platelet aggregation in obliterating arteriopathies of the lower limbs. Preliminary findings].
    Rossi M; Evangelisti L; Giusti C; Santoro G; Pentimone F; Camici M
    Minerva Cardioangiol; 1982 Jun; 30(6):329-33. PubMed ID: 7133421
    [No Abstract]   [Full Text] [Related]  

  • 7. [Platelet function, serum lipoproteins and clinical aspects in peripheral arterial occlusive disease].
    Kaliman J
    Acta Med Austriaca Suppl; 1982; 26():1-25. PubMed ID: 6762030
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study on the relationship of plasma fibrinogen, platelet aggregation rate and peripheral arterial occlusive disease].
    Wang J; Li XY; He Y; Ni B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jan; 26(1):1-4. PubMed ID: 15921581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of age, sex, smoking, and diabetes on lower limb transcutaneous oxygen tension in patients with arterial occlusive disease.
    Rooke TW; Osmundson PJ
    Arch Intern Med; 1990 Jan; 150(1):129-32. PubMed ID: 2297283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Do passive smokers have an increased risk of thrombosis?].
    Sinzinger H; Virgolini I
    Wien Klin Wochenschr; 1989 Oct; 101(20):694-8. PubMed ID: 2588591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood viscosity, mass transport, and thrombogenesis.
    Turitto VT
    Prog Hemost Thromb; 1982; 6():139-77. PubMed ID: 6762611
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of antithrombotic effect in drug therapy of the chronic arterial occlusive disease.
    Angelkort B
    Ric Clin Lab; 1981; 11 Suppl 1():215-21. PubMed ID: 7188109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of peripheral arterial occlusive disease, risk factors and rheologic profile: results of a preliminary examination in the Aachen study].
    Kiesewetter H; Jung F; Witt R; Kotitschke G; Winkelhog C; Nüttgens HP; Gerhards M; Roebruck P; Waterloh E
    Vasa Suppl; 1987; 20():266-9. PubMed ID: 3501171
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood fluidity in essential hypertension, arterial occlusive disease and diabetic angiopathies].
    Sternitzky R; Hänsgen K; Podhaisky H
    Z Gesamte Inn Med; 1991 Nov; 46(16):610-4. PubMed ID: 1792802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD-study.
    Breddin HK; Krzywanek HJ; Althoff P; Kirchmaier CM; Rosak C; Schepping M; Weichert W; Ziemen M; Schöffling K; Uberla K
    Int Angiol; 1986; 5(3):181-95. PubMed ID: 3104511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of hyperuricemia in chronic arterial occlusive disease and in post-thrombotic syndrome].
    Marx H
    Verh Dtsch Ges Kreislaufforsch; 1974; 40():233-5. PubMed ID: 4450657
    [No Abstract]   [Full Text] [Related]  

  • 17. [Synergism of PGI2 and molsidomine in arterial occlusive disease].
    Sinzinger H
    Z Kardiol; 1991; 80 Suppl 5():51-3. PubMed ID: 1776336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of normal and pathologic physicochemical surface conditions and various pore diameters on erythrocyte filterability in patients with arterial occlusive disease and control patients of the same age].
    Steinbach U; Scheffler A; Rieger H
    Vasa Suppl; 1988; 23():294-6. PubMed ID: 3206347
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of hydrostatic pressure, environmental temperature and age, sex and smoking history on transcutaneous oxygen partial pressure measurement].
    Lentner A; Younossi H; Planz S; Wienert V
    Vasa Suppl; 1991; 32():243-6. PubMed ID: 1771506
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombophilia in patients with arterial occlusive diseases and its therapeutic modification].
    Norden C; Reimann H; Grunow G; Misselwitz F
    Vasa Suppl; 1991; 32():300-4. PubMed ID: 1771519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.